Literature DB >> 12779138

Calcific aortic stenosis: another face of atherosclerosis?

Gian M Novaro1, Brian P Griffin.   

Abstract

Calcific aortic stenosis is not the result of decades of wear and tear alone. Rather, it is being increasingly recognized as an inflammatory, atheromatous, and potentially modifiable disease. Exciting new research suggests that medical therapies may soon be available to retard its progression and reduce the need for surgery.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12779138     DOI： 10.3949/ccjm.70.5.471

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  9 in total

1.  Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.

Authors:  Ashvin R Kamath; Ramdas G Pai
Journal:  Int J Angiol       Date:  2008

2.  Administration of angiotensin-converting enzyme inhibitors is associated with slow progression of mild aortic stenosis in Japanese patients.

Authors:  Kana Wakabayashi; Takeshi Tsujino; Yoshiro Naito; Akira Ezumi; Masaaki Lee-Kawabata; Shinji Nakao; Akiko Goda; Yasushi Sakata; Kazuhiro Yamamoto; Takashi Daimon; Tohru Masuyama
Journal:  Heart Vessels       Date:  2010-11-10       Impact factor: 2.037

3.  Networked-based characterization of extracellular matrix proteins from adult mouse pulmonary and aortic valves.

Authors:  Peggi M Angel; David Nusinow; Chris B Brown; Kate Violette; Joey V Barnett; Bing Zhang; H Scott Baldwin; Richard M Caprioli
Journal:  J Proteome Res       Date:  2010-12-22       Impact factor: 4.466

4.  Surface chemistry regulates valvular interstitial cell differentiation in vitro.

Authors:  Matthew N Rush; Kent E Coombs; Elizabeth L Hedberg-Dirk
Journal:  Acta Biomater       Date:  2015-09-30       Impact factor: 8.947

5.  iTRAQ proteomic analysis of extracellular matrix remodeling in aortic valve disease.

Authors:  Tatiana Martin-Rojas; Laura Mourino-Alvarez; Sergio Alonso-Orgaz; Esther Rosello-Lleti; Enrique Calvo; Luis Fernando Lopez-Almodovar; Miguel Rivera; Luis R Padial; Juan Antonio Lopez; Fernando de la Cuesta; Maria G Barderas
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

6.  Association between homocysteine levels and calcific aortic valve disease: a systematic review and meta-analysis.

Authors:  Guandi Wu; Jiayi Xian; Xi Yang; Jiaying Li; Jichen Liu; Wenhui Dong; Shuwen Su; Jun Li; Yan Tu; Jian Peng; Dingli Xu; Qingchun Zeng
Journal:  Oncotarget       Date:  2018-01-03

7.  Lipoprotein(a) Gene Polymorphism Increases a Risk Factor for Aortic Valve Calcification.

Authors:  Ugur Ozkan; Fatih Ozcelik; Mustafa Yildiz; Metin Budak
Journal:  J Cardiovasc Dev Dis       Date:  2019-08-26

8.  The Influence of Coronary Artery Disease in the Development of Aortic Stenosis and the Importance of the Albumin Redox State.

Authors:  Tamara Sastre-Oliva; Nerea Corbacho-Alonso; Diego Albo-Escalona; Juan A Lopez; Luis F Lopez-Almodovar; Jesús Vázquez; Luis R Padial; Laura Mourino-Alvarez; Maria G Barderas
Journal:  Antioxidants (Basel)       Date:  2022-02-05

9.  Increased serum chemerin level to predict early onset of aortic valve stenosis.

Authors:  Juris Lurins; Dace Lurina; Peteris Tretjakovs; Vitolds Mackevics; Aivars Lejnieks; Venerando Rapisarda; Vincenzo Baylon
Journal:  Biomed Rep       Date:  2017-11-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.